Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of miRNAs in Alzheimer’s Disease and Possible Fields of Application
Serena Silvestro, Placido Bramanti, Emanuela Mazzon
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 16, pp. 3979-3979
Open Access | Times Cited: 97

Showing 51-75 of 97 citing articles:

Hsa_circ_0049472 contributed to amyloid-beta peptide-induced neurotoxicity, apoptosis and inflammation via regulating PI3K-AKT signaling pathway by interacting with miR-22–3p/ZNF217 axis
Yuanrun Xie, Dan Xie, Chao Chen
Brain Research Bulletin (2024) Vol. 215, pp. 111004-111004
Open Access | Times Cited: 2
Nexus of NFκB/VEGF/MMP9 signaling in diabetic retinopathy-linked dementia: Management by phenolic acid-enabled nanotherapeutics
Vikrant Singh, Siva Prasad Panda
Life Sciences (2024), pp. 123123-123123
Closed Access | Times Cited: 2
Hyper-graph based sparse canonical correlation analysis for the diagnosis of Alzheimer’s disease from multi-dimensional genomic data
Wei Shao, Shunian Xiang, Zuoyi Zhang, et al.
Methods (2020) Vol. 189, pp. 86-94
Closed Access | Times Cited: 19
Common aspects between glaucoma and brain neurodegeneration
Sergio Claudio Saccà, Filippo Paluan, Stefano Gandolfi, et al.
Mutation Research/Reviews in Mutation Research (2020) Vol. 786, pp. 108323-108323
Closed Access | Times Cited: 18
Epigenetic regulation of synaptic disorder in Alzheimer’s disease
Zhiying Chen, Moxin Wu, Qin Lai, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 12
Protective effect of a standardized Allium jesdianum extract in an Alzheimer's disease induced rat model
Farzaneh Kamranfar, Razieh Pourahmad Jaktaji, Kobra Shirani, et al.
Neuroscience Letters (2023) Vol. 815, pp. 137491-137491
Closed Access | Times Cited: 6
Endometrial microRNAs and their aberrant expression patterns
Shunsuke Tamaru, Takeshi Kajihara, Yosuke Mizuno, et al.
Medical Molecular Morphology (2020) Vol. 53, Iss. 3, pp. 131-140
Closed Access | Times Cited: 17
MicroRNAs Modulate the Pathogenesis of Alzheimer’s Disease: An In Silico Analysis in the Human Brain
Agnese Gugliandolo, Luigi Chiricosta, Virginia Boccardi, et al.
Genes (2020) Vol. 11, Iss. 9, pp. 983-983
Open Access | Times Cited: 16
The Relationship between the Aberrant Long Non-Coding RNA-Mediated Competitive Endogenous RNA Network and Alzheimer’s Disease Pathogenesis
Zhongdi Cai, Kaiyue Zhao, Li Zeng, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8497-8497
Open Access | Times Cited: 10
Exosomal miRNA-223-3p as potential biomarkers in patients with cerebral small vessel disease cognitive impairment
Weina Zhao, Wenqiang Sun, Siou Li, et al.
Annals of Translational Medicine (2021) Vol. 9, Iss. 24, pp. 1781-1781
Open Access | Times Cited: 14
MicroRNA‐340‐5p increases telomere length by targeting telomere protein POT1 to improve Alzheimer's disease in mice
Xin Li, Jiangkuan Zhang, Yuhang Yang, et al.
Cell Biology International (2021) Vol. 45, Iss. 6, pp. 1306-1315
Closed Access | Times Cited: 13
The long and short: Non-coding RNAs in the mammalian inner ear
Tal Koffler-Brill, Yael Noy, Karen B. Avraham
Hearing Research (2022) Vol. 428, pp. 108666-108666
Open Access | Times Cited: 9
Systematic Search for Novel Circulating Biomarkers Associated with Extracellular Vesicles in Alzheimer’s Disease: Combining Literature Screening and Database Mining Approaches
David Vogrinc, Katja Goričar, Tanja Kunej, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 10, pp. 946-946
Open Access | Times Cited: 12
The potential of five c-miRNAs as serum biomarkers for Late-Onset Alzheimer’s disease diagnosis: miR-10a-5p, miR-29b-2-5p, miR-125a-5p, miR-342-3p, and miR-708-5p
Isadora de Lourdes Signorini-Souza, Luciane Viater Tureck, Meire Silva Batistela, et al.
Brain Research (2024) Vol. 1841, pp. 149090-149090
Closed Access | Times Cited: 1
Therapeutic potential of stem cells and acitretin on inflammatory signaling pathway-associated genes regulated by miRNAs 146a and 155 in AD-like rats
Emad M. Elzayat, Sherif A. Shahien, Ahmed A. El‐Sherif, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Investigating metabolic dysregulation in serum of triple transgenic Alzheimer’s disease male mice: implications for pathogenesis and potential biomarkers
Hongbin Zhuang, Xueshan Cao, Xiaoxiao Tang, et al.
Amino Acids (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 1
The Clinical Aspects of COVID and Alzheimer’s Disease: A Round-Up of Where Things Stand and Are Headed
José Wagner Leonel Tavares-Júnior, Gabriella Cunha Vieira Ciurleo, Esther de Alencar Araripe Falcão Feitosa, et al.
Journal of Alzheimer s Disease (2024) Vol. 99, Iss. 4, pp. 1159-1171
Closed Access | Times Cited: 1
Insights into the Role of microRNAs as Clinical Tools for Diagnosis, Prognosis, and as Therapeutic Targets in Alzheimer’s Disease
Nidhi Puranik, Minseok Song
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9936-9936
Open Access | Times Cited: 1
miRNA-Based Signature to Predict the Development of Alzheimer’s Disease
Longfei Chen, Fangfang Zhan, Jin‐Shan Yang, et al.
Combinatorial Chemistry & High Throughput Screening (2022) Vol. 25, Iss. 12, pp. 2103-2111
Closed Access | Times Cited: 6
miR-590-5p Overexpression Alleviates β-Amyloid-Induced Neuron Damage via Targeting Pellino-1
Shang Lin, Tao Peng, Xuemei Chen, et al.
Analytical Cellular Pathology (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 6
MiR-214-3p Prevents the Development of Perioperative Neurocognitive Disorders in Elderly Rats
Yuhao Wang, Yong-Wang Chen, Wanli Xiao, et al.
Current Medical Science (2022) Vol. 42, Iss. 4, pp. 871-884
Closed Access | Times Cited: 6
MicroRNAs as Possible Biomarkers for Diagnosis and Therapy of Alzheimer’s Disease by Regulating the Abnormal Expression of Genes Related to Tau
Mengzhu Tang
BIO Web of Conferences (2023) Vol. 60, pp. 01001-01001
Open Access | Times Cited: 2
Differential microRNA expression analyses across two brain regions in Alzheimer’s disease
Valerija Dobričić, Marcel Schilling, Jessica Schulz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 5
Small RNA Sequencing in the Tg4–42 Mouse Model Suggests the Involvement of snoRNAs in the Etiology of Alzheimer’s Disease
Chit Tong Lio, Tim Kacprowski, Maik Klaedtke, et al.
Journal of Alzheimer s Disease (2022) Vol. 87, Iss. 4, pp. 1671-1681
Closed Access | Times Cited: 3
Noncoding RNAs in Alzheimer’s Disease: Overview of Functional and Therapeutic Significance
Divya Adiga, Sangavi Eswaran, Sriharikrishnaa Srinath, et al.
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 19, pp. 1615-1634
Closed Access

Scroll to top